A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Clinical trial NCT06271512 · RECRUITING
Trial details
- NCT number
- NCT06271512
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-23
- Primary completion
- 2043-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.